Life Insurance With a High BMI in the UK: What's Changed in 2026

The relationship between BMI, life insurance underwriting, and newer weight-loss medications is one of the most rapidly evolving areas in the UK protection market right now. Here's what you need to know.

How UK Insurers Use BMI in Underwriting

Body Mass Index has been a standard factor in life insurance underwriting for decades. The reasoning is straightforward: higher BMI is statistically associated with an increased risk of type 2 diabetes, cardiovascular disease, sleep apnoea, and certain cancers — all of which affect life expectancy and therefore the insurer's risk.

Most UK insurers use BMI thresholds to apply loadings (premium increases) or, at the extreme end of the scale, to decline applications. The thresholds vary by insurer, but a common pattern is:

• BMI under 30: Standard rates for most providers (some apply a small loading at 28–30)
• BMI 30–35: Possible loading, depending on other health factors
• BMI 35–40: Loading is likely; some providers require additional medical information
• BMI over 40: Significant loading or decline at standard terms; specialist insurers may still offer cover

It's important to note that BMI is rarely the only factor considered. Insurers look at the full picture: blood pressure, blood glucose, cholesterol, family history, and lifestyle. A person with a BMI of 36 who has no other health conditions, does not smoke, and has excellent blood pressure and glucose control will be viewed very differently from someone with the same BMI who also has poorly controlled type 2 diabetes and a family history of cardiovascular disease.

The Impact of GLP-1 Medications on Underwriting

The arrival of GLP-1 receptor agonist medications — the class that includes semaglutide (sold under brand names including Ozempic and Wegovy) and tirzepatide — has introduced a genuinely new variable into weight-related underwriting.

These medications have produced weight-loss results that were not previously achievable through diet and lifestyle intervention alone. Clinical trials have demonstrated average weight reductions of roughly 15% to 20% of body weight, depending on the medication and the study.

For life insurance underwriting, this creates an interesting question: how should an insurer treat an applicant with a current BMI of 38 who has been using a GLP-1 medication for 12 months and whose BMI was 45 a year ago? Their trajectory is very different from someone whose BMI has been stable at 38 for a decade.

UK insurers are responding to this in different ways, and the underwriting approach is still developing. Some key points to understand:

Some underwriters may take your weight-loss trajectory into account. If an applicant is demonstrably losing weight on medication, and their other health markers (blood pressure, glucose, cholesterol) are improving as a result, some underwriters may factor this trajectory into their assessment rather than rating purely on current BMI.

Not all insurers have updated their criteria yet. Others may still apply BMI loadings based on the number at the time of application, without accounting for the medication's effect on likely future BMI. This is one of the reasons why working with a broker who understands current underwriting criteria across multiple providers matters particularly for this group.

The medication itself may be noted. When you list current medications on an application, GLP-1 drugs will appear. Underwriters may ask follow-up questions about the reason for prescription — whether it's weight management, type 2 diabetes, or cardiovascular risk reduction — as the underlying condition matters as much as the medication.

If You've Lost Weight Recently: Timing Your Application

If you've lost a significant amount of weight — whether through medication, surgery, or lifestyle change — the timing of your life insurance application can affect the outcome.

Many insurers want to see weight stability before assigning rates. If you lost 20kg in the past six months, an insurer may prefer to see that weight maintained for 12–24 months before offering the most favourable terms. Applying too early after rapid weight loss can result in higher premiums than waiting until your new weight is established.

However, this doesn't mean you should delay indefinitely. Some cover now — even at a loaded rate — is better than no cover. And if your weight continues to fall, you can reapply or request a review of your existing policy.

Weight Loss Surgery and Life Insurance

Bariatric surgery — including gastric bypass, sleeve gastrectomy, and gastric band procedures — is another weight-related factor that UK underwriters assess individually.

In the immediate post-operative period (typically the first 12–24 months), many insurers will not offer cover or will offer it at significantly loaded rates, due to the risk of surgical complications and the adjustment period. Once you have a period of stable weight post-surgery, with regular medical check-ups and no complications, most providers will offer cover — often at rates that reflect your post-surgery weight rather than your pre-surgery weight.

If you've had weight loss surgery in the past, be prepared to provide surgical notes, details of any complications, and evidence of current weight and health status.

Why Insurers Disagree About Build

Build — your height against your weight — is one of the areas where UK insurers differ most from one another. Each sets its own internal thresholds at which terms begin to change, and the same reading can attract standard rates at one insurer, a loading at a second and a postponement at a third. There is no contradiction in that: each insurer is pricing against its own claims experience and reinsurance arrangements.

Three outcomes are worth distinguishing. A loading means cover is available at a higher premium, usually scaled to the reading. A postponement means the insurer wants to look again after a set period, often once weight or a related marker has stabilised. A decline means that insurer will not offer cover on that basis today. Only the last closes a door, and usually only at that insurer — which is why placing a higher-BMI case with the right insurer first time matters more than submitting it to several in turn.

Getting the Right Cover

The key message for anyone with a high BMI seeking life insurance is this: the market is not closed to you, and the outcome varies significantly depending on which insurer you approach and how your application is presented.

A whole-of-market broker can identify which providers are currently most favourable for your specific profile — BMI, other health factors, medication use, and trajectory — and present your application in the most accurate and complete way. This is particularly important as the underwriting response to GLP-1 medications continues to evolve; what was true six months ago may already have changed.

Don't assume a decline from one insurer is the final answer. In a market that is actively adapting to new medical realities, a second opinion is always worth seeking.